🇺🇸 FDA
Patent

US 9617303

Sustained-release composition and method for producing the same

granted A61KA61K31/55A61K38/00

Quick answer

US patent 9617303 (Sustained-release composition and method for producing the same) held by Takeda Pharmaceutical Company Limited expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/55, A61K38/00, A61K38/08, A61K38/095